Rocket Pharmaceuticals
RCKT
RCKT
34 hedge funds and large institutions have $15.9M invested in Rocket Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less funds holding
Funds holding: 51 → 34 (-17)
76% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 21
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
34
Holding in Top 10
–
Calls
$33K
Puts
$6K
Top Buyers
| 1 | +$3.21M | |
| 2 | +$2.77M | |
| 3 | +$1.83M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.13M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$537K |
Top Sellers
| 1 | -$4.99M | |
| 2 | -$656K | |
| 3 | -$451K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$404K |
| 5 |
Goldman Sachs
New York
|
-$330K |